| Literature DB >> 22768309 |
Ole Herman Ambur1, Stephan A Frye, Mariann Nilsen, Eirik Hovland, Tone Tønjum.
Abstract
Transformation is a complex process that involves several interactions from the binding and uptake of naked DNA to homologous recombination. Some actions affect transformation favourably whereas others act to limit it. Here, meticulous manipulation of a single type of transforming DNA allowed for quantifying the impact of three different mediators of meningococcal transformation: NlaIV restriction, homologous recombination and the DNA Uptake Sequence (DUS). In the wildtype, an inverse relationship between the transformation frequency and the number of NlaIV restriction sites in DNA was observed when the transforming DNA harboured a heterologous region for selection (ermC) but not when the transforming DNA was homologous with only a single nucleotide heterology. The influence of homologous sequence in transforming DNA was further studied using plasmids with a small interruption or larger deletions in the recombinogenic region and these alterations were found to impair transformation frequency. In contrast, a particularly potent positive driver of DNA uptake in Neisseria sp. are short DUS in the transforming DNA. However, the molecular mechanism(s) responsible for DUS specificity remains unknown. Increasing the number of DUS in the transforming DNA was here shown to exert a positive effect on transformation. Furthermore, an influence of variable placement of DUS relative to the homologous region in the donor DNA was documented for the first time. No effect of altering the orientation of DUS was observed. These observations suggest that DUS is important at an early stage in the recognition of DNA, but does not exclude the existence of more than one level of DUS specificity in the sequence of events that constitute transformation. New knowledge on the positive and negative drivers of transformation may in a larger perspective illuminate both the mechanisms and the evolutionary role(s) of one of the most conserved mechanisms in nature: homologous recombination.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22768309 PMCID: PMC3388099 DOI: 10.1371/journal.pone.0039742
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Sequence characteristics of transforming DNA. A. Variable DUS positions and restriction profiles in transforming DNA plasmids.
Transforming DNA plasmids are based on pilG (black) interrupted by an erythromycin resistance insert, ermC, (gray). DUS (5′- ATGCCGTCTGAA-3′) or reverse complimentary DUS (5′-TTCAGACGGCAT-3′) are inserted in three different positions A, B and C as marked above the bar. All numbers refer to the nucleotide position following the start codon (1) of pilG. The 137 nucleotide long BamHI-fragment which is removed in pDV-b, pDV-c versions is shown in white with black stripes. B. IV restriction profile of and location of selective SNP. The homologous 723 nt long PCR fragment of an internal part of the meningococcal rpoB gene used in transformation contains two NlaIV restriction sites on both sides of the selective SNP responsible for rifampicin resistance in the recipient.
Figure 2NlaIV restriction affects plasmid transformation in N. meningitidis MC58 wildtype and not the NlaIV null mutant.
The Y axis shows the number of resistant (erythromycin) CFU/total 1010 CFU on a log scale. Along the X-axis are the different DNA substrates (10 ng/ml) with altered numbers of NlaIV restriction sites shown. pDV4-a harbours two and three NlaIV restriction sites more than pDV4-b and pDV4-c, respectively. For further details of the restriction profiles and DUS locations in the transforming DNA plasmids please consult Figure 1 and Table 2. Statistically significant differences in transformation frequencies between the NlaIV null mutant and wildtype backgrounds are indicated above the columns, ***equals p≤0.001 in a two tailed paired student’s t-test.
Figure 3NlaIV restriction does not affect homologous DNA transformation in N. meningitidis MC58 wildtype or in the NlaIV null mutant.
The Y axis shows the number of rifampicin-resistant CFU/total CFU 109 on a log scale. Along the X-axis are shown the two different DNA substrates (5 ng/ml), rpoB PCR fragment and rpoB PCR fragment pre-digested with NlaIV. For further details on the transforming DNA please consult Figure 1 and Table 2. The transformation frequencies in the wildtype and in the NlaIV null mutant backgrounds are not statistically significant from each other.
Plasmids and bacterial strains.
| Plasmids | Relevant characteristics, DUS position(s) and orientation(s) in () | Source |
| pBluescript II SK+ | General cloning vector, ampr, abbreviated pBSK+ | Stratagene |
| p0-DUS-a | pBSK+ harbouring |
|
| p0-DUS-b | p0-DUS with 137 nt removed incl. two | This study |
| p0-DUS-c | p0-DUS-b w/one | This study |
| pSingle | pBSK+ harbouring |
|
| pOHA13-c | pSingle w/137 nt and and three | This study |
| pOHA13r-c | pOHA13-c with DUS reversed (Br) | This study |
| pDV1-a | p0-DUS-a w/DUS in position C (Cf) | |
| pDV1-b | p0-DUS-b w/DUS in position C (Cf) | |
| pDV1-c | p0-DUS-c w/DUS in position C (Cf) | This study |
| pDV-c-d1 | pOHAD1-c w/74 nt deletion from 396 nt into | This study |
| pDV1-c-d2 | pDV1-c w/561 nt deletion from | This study |
| pDV1-c-d3 | pDV1-c w/808 nt deletion from | This study |
| pDV4-a | p0-DUS-a w/forward DUS in position A (Af) | This study |
| pDV4-b | pDV4-a w/137 nt removed incl. two | This study |
| pDV4-c | pDV4-b w/one | This study |
| pDV5-c | p0-DUS-c w/forward DUS in positions A and C (AfCf) | This study |
| pDV6-c | p0-DUS-c w/forward DUS in positions A, B and C (AfBfCf) | This study |
| pDV54 | p0-DUS-c w/reverse DUS in positions A (Ar) | This study |
| pDV55 | p0-DUS-c w/reverse DUS in positions C (Cr) | This study |
| pDV57 | p0-DUS-c w/reverse DUS in positions A and C (ArCr) | This study |
| pDV58 | p0-DUS-c w/reverse DUS in positions A and forward DUS in position C (ArCf) | This study |
| pDV59 | p0-DUS-c w/forward DUS in positions A and reverse DUS in position C (AfCr) | This study |
| pOHA1032:: | pBSK+ with partial | This study |
| pUP6 | Substrate for PCR of kanamycin resistance gene |
|
|
| ||
|
|
| Stratagene |
|
|
|
|
|
| Restriction endonuclease | This study |
Figure 4Deletions in the recombinogenic region of plasmids impose a negative influence on transformation.
The Y axis shows the number of erythromycin-resistant CFU/total CFU 108 on a log scale. Along the X-axis are shown the different transforming plasmids (1 µg/ml) with altered regions of homology. For further details on the transforming DNA please consult Figure 1 and Table 2. Differences in transformation frequencies are statistically significant from each other as indicated above the columns, **equals p≤0.05 in student’s t-tests.
Figure 5Effects of DUS orientation, location and multiplication on transformation.
The Y axis shows the efficacy of transformation as percent of the transformation obtained with the internal standard Af plasmid (pDV4-c). Along the X-axis are shown the different DNA substrates (10 ng/ml) identical in all but DUS in three different positions (A, B and C), in two different orientations, forward (f) and reverse (r), and in the combinations of these. For further details on the DNA plasmid templates please consult Figure 1 and Table 2. Statistically significant values are indicated above the columns, **equals p≤0.05 and ***equals p≤0.001 in a two-tailed paired student’s t tests.
Figure 6The influence of DUS location on transformation.
The Y axis shows the number of erythromycin-resistant CFU/total CFU 108 on a log scale. Along the X-axis are shown the transforming DNA (1 µg/ml) that differ in NlaIV restriction profiles and DUS location. For further details on the DNA plasmid templates please consult Figure 1 and Table 2. Statistically significant values are indicated above the columns, **equals p≤0.05 and ***equals p≤0.001 in a two-tailed paired student’s t tests.
Fold-differences and statistical significance values (paired two tailed student’s t tests) in comparing the performances of individual plasmids harbouring DUS in the C (pDV1) or A (pDV4) positions in transformation of the NlaIV mutant and wt backgrounds.
| MC58 ΔnlaIVR | |||
| pDV1-a | pDV1-b | pDV1-c | |
| pDV4-a | 1.7 fold, p = 0.0002 (N = 8) | – | – |
| pDV4-b | – | 1.7-fold, p≤0.0001 (N = 8) | – |
| pDV4-c | – | – | 2.2-fold, p≤0.0001 (N = 8) |
| MC58 wt | |||
| pDV4-a | 1.3-fold, p = 0.1203 (N = 10) | – | – |
| pDV4-b | – | 1.8-fold, p = 0.0044 (N = 10) | – |
| pDV4-c | – | – | 1.9-fold, p = 0.0004 (N = 10) |
N denotes the number of replicate experiments.
Primers.
| Primer name | Primer sequence | Usage | Reference |
| 3892OH11_ |
| Multiple plasmids |
|
| 8907OHA11_DUS |
| w/DUS in pos. Af | This study |
| 3893OH3 |
| Multiple plasmids | |
| 8908OHA3_DUS |
| w/DUS in pos. Cf | This study |
| 11368SF129 |
| w/DUS in pos. Ar | This study |
| 11369SF130 |
| w/DUS in pos. Cr | This study |
| 10324OHA2020 |
| pOHA1032:: | This study |
| 10325OHA2021 |
| pOHA1032:: | This study |
| 10326OHA2022 |
| pOHA1032:: | This study |
| 10327OHA2023 |
| pOHA1032:: | This study |
| 10327OHA2023 |
| pOHA1032:: | This study |
| 8184OHA_ | GCGAATTCTCATTTCGAACCCC-AGAGTC | pOHA1032:: | This study |
| 12950OHA2187 |
| w/DUS in pos. Br | This study |
| 12951OHA2188 |
| w/DUS in pos. Br | This study |
| S1 |
| Sequencing |
|
| S2 |
| Sequencing |
|
| S3 |
| Sequencing |
|
| PR2488 |
| Sequencing |
|
| PR2487 |
| Sequencing |
|
| 13573OHA2220 |
| Version –d | This study |
| 13574OHA2221 |
| Version –d | This study |
| 31567OHA2217 |
|
| This study |
| 31568OHA2218 |
|
| This study |